Sam Eiber
Stock Analyst at BTIG
(0.37)
# 4,140
Out of 5,180 analysts
15
Total ratings
18.18%
Success rate
-20.91%
Average return
Main Sectors:
Stocks Rated by Sam Eiber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APYX Apyx Medical | Upgrades: Buy | $6 | $3.69 | +62.60% | 2 | Mar 11, 2026 | |
| SBC SBC Medical Group Holdings | Initiates: Buy | $8 | $4.14 | +93.24% | 1 | Mar 6, 2026 | |
| EOLS Evolus | Reiterates: Buy | $13 | $4.11 | +216.30% | 5 | Mar 4, 2026 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $86 → $88 | $56.75 | +55.07% | 4 | Feb 24, 2026 | |
| MMSI Merit Medical Systems | Initiates: Buy | $107 | $68.93 | +55.23% | 1 | Feb 6, 2026 | |
| INMD InMode | Downgrades: Neutral | n/a | $13.68 | - | 2 | Apr 29, 2025 |
Apyx Medical
Mar 11, 2026
Upgrades: Buy
Price Target: $6
Current: $3.69
Upside: +62.60%
SBC Medical Group Holdings
Mar 6, 2026
Initiates: Buy
Price Target: $8
Current: $4.14
Upside: +93.24%
Evolus
Mar 4, 2026
Reiterates: Buy
Price Target: $13
Current: $4.11
Upside: +216.30%
Establishment Labs Holdings
Feb 24, 2026
Maintains: Buy
Price Target: $86 → $88
Current: $56.75
Upside: +55.07%
Merit Medical Systems
Feb 6, 2026
Initiates: Buy
Price Target: $107
Current: $68.93
Upside: +55.23%
InMode
Apr 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $13.68
Upside: -